Cargando…
EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation
BACKGROUND: Our previous studies demonstrated that eyes absent homolog 4 (EYA4), a member of the eye development-related EYA family in Drosophila, is frequently methylated and silenced in hepatocellular carcinoma (HCC) specimens and associated with shorter survival. The current work aimed to explore...
Autores principales: | Mo, Shi-Jing, Hou, Xun, Hao, Xiao-Yi, Cai, Jian-Peng, Liu, Xin, Chen, Wei, Chen, Dong, Yin, Xiao-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993152/ https://www.ncbi.nlm.nih.gov/pubmed/29764501 http://dx.doi.org/10.1186/s40880-018-0276-1 |
Ejemplares similares
-
EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β‐catenin at Ser552
por: Zhu, Xiao‐Xu, et al.
Publicado: (2019) -
EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma
por: Hao, Xiao-Yi, et al.
Publicado: (2016) -
EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling
por: Liu, Ze-Kun, et al.
Publicado: (2021) -
Eya mater
Publicado: (1995) -
EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis
por: Gu, Fangming, et al.
Publicado: (2019)